Preferences for Certainty Versus Access When Evaluating New Cancer Drugs. A Discrete Choice Experiment.

NCT05936632 · clinicaltrials.gov ↗
COMPLETED
Status
998
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

London School of Economics and Political Science